The Philadelphia Inquirer recently covered Fideres’s recent research on price increases of generic drugs as part of a full examination of the pharmaceutical industry. Alberto Thomas, founding partner at Fideres, [...]
Fideres’s research on generic drug pricing was covered today by Bloomberg. The research analysed price increases for individual generic drugs among different manufacturers and the timings of these price increases. [...]
Labaton and Hausfeld have filed a class action in the U.S. alleging a conspiracy in the Supranational, Sub-sovereign and Agency bonds (SSA) market. Fideres’s analysis has been included in the [...]
Labaton and Hausfeld have filed a class action in the U.S. alleging a conspiracy in the Supranational, Sub-sovereign and Agency bonds (SSA) market. Fideres’s analysis has been included in the [...]
